Sign in

Martin Marietta Materials, Inc. MLM

Price 508.9 USD
as of 2026-09-05
38/100
Weak
Quality46
Growth29
Balance-sheet strength54
Valuation31
Momentum19
Income45

Composite 38/100; the shares have moved about 31% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 19/100 — a strong mark against it.

Case for

Balance-sheet strength ranks 54/100 — a slight point in its favour.

Case against

Momentum ranks 19/100 — a strong mark against it. Growth ranks 29/100 — a moderate mark against it. Valuation ranks 31/100 — a moderate mark against it.

What the company does Martin Marietta Materials (MLM) supplies aggregates (crushed stone, sand, gravel), ready-mixed concrete, asphalt, and magnesia-based chemicals across US infrastructure, nonresidential/residential construction, and industrial markets.

Key financials ROE 9%, ROA 5%, ROCE 7%; gross/operating/net margins 28%/20%/37%. Revenue grew 21% but EPS fell 23% year-over-year. Debt/equity 0.55, net debt/EBITDA 2.93, interest coverage 6.05.

Stock health SiderAxia overall score 39/100 (Weak quality, richly valued, weak momentum). Quality 48, Growth 35, Momentum 25. Piotroski F-Score 5/9, Altman Z 3.11. RSI 38, down 26% from 52-week high.

Price vs fair value The stock trades at a discount of 27% versus the analyst mean target of 663.74. - Analysts question whether MLM can justify its premium valuation as earnings growth improves (Zacks). - Recent coverage highlights MLM’s “rocks and gravel” theme and out-of-favor status (Insider Monkey; StockStory). - Simply Wall St suggests MLM may trade below fair value today.

Looking forward Forward P/E 29.24, PEG 1.33, EV/EBITDA 18.82. Dividend yield 0.6%, payout 18%. Long-term growth hinges on execution of the $13.5B Lhoist deal and sustained infrastructure demand.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.